Catalyst Pharmaceuticals, Inc.
CPRXDelisted Jul 15, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001369568
Catalyst Pharmaceuticals, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 396 institutions reported holding it in 13F filings for Q2 2026, worth $3.39B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2024 vs. Q2 2024
How the institutions holding Catalyst Pharmaceuticals, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 271 | 2 | 316 | +47 |
| Shares | 96.9M | 18.7M | 95.5M | +17.3M (+22.1%) |
| Value | $1.50B | $289.8M | $1.90B | +$687.6M (+56.7%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (68)
Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (21)
Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Point72 Asset Management, L.P. | 618,296 | $9.58M |
| Sphera Funds Management Ltd. | 288,000 | $4.46M |
| Balyasny Asset Management LLC | 51,815 | $802.6K |
| Y-Intercept (Hong Kong) Ltd | 40,174 | $622.3K |
| UniSuper Management Pty Ltd | 28,265 | $437.8K |
| Gallacher Capital Management LLC | 18,564 | $287.6K |
| Quarry LP | 16,334 | $253.0K |
| Sumitomo Mitsui Trust Holdings, Inc. | 14,800 | $229.3K |
| Strategic Advocates LLC | 14,142 | $219.1K |
| Prospera Financial Services Inc | 12,128 | $187.9K |
| GTS Securities LLC | 11,845 | $183.5K |
| PVG Asset Management Corp | 11,786 | $182.6K |
| E Fund Management Co., Ltd. | 11,266 | $174.5K |
| Wolverine Trading, LLC | 10,609 | $164.3K |
| Daiwa Securities Group Inc. | 10,200 | $158.0K |
| Point72 Asia (Singapore) Pte. Ltd. | 9,857 | $152.7K |
| Cubist Systematic Strategies, LLC | 8,523 | $132.0K |
| New Vernon Capital Holdings II LLC | 7,864 | $121.8K |
| Innealta Capital, LLC | 162 | $2.51K |
| GWM Advisors LLC | 70 | $1.08K |
| Aspire Private Capital, LLC | 20 | $310 |
Not filed for Q3 2024 yet (2)
Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 18,694,918 | $289.6M |
| Susquehanna Fundamental Investments, LLC | 16,683 | $258.4K |